SCHEMBL11904990

SCHEMBL11904990

Cc1ccc(S(=O)(=O)n2c(C(=O)/C(C#N)=C\N(C)C)cc3cc(CN4CCCC4)c(F)cc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.43
▸ NOD2 Q9HC29 2/20 0.35
▸ NOD1 Q9Y239 2/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ DPP4 P27487 1/20 0.32
▸ PKM P14618 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TP53 P04637 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16015321 1.00 ALOX5 (0.43) ALOX5NOD2NOD1HRH3THRB
SCHEMBL11904992 1.00 ALOX5 (0.43) ALOX5NOD2NOD1HRH3THRB
SCHEMBL10003966 0.94 HTR6 (0.39) ALOX5NOD2NOD1THRBCYP3A4
SCHEMBL10003964 0.94 HTR6 (0.39) ALOX5NOD2NOD1THRBCYP3A4
SCHEMBL11931229 0.94 HTR6 (0.39) ALOX5NOD2NOD1THRBCYP3A4
SCHEMBL18332262 0.86 NOD2 (0.41) ALOX5NOD2NOD1ALDH1A1NPSR1
SCHEMBL10003580 0.83 ALOX5 (0.39) ALOX5NOD2NOD1ALDH1A1NPSR1
SCHEMBL10003582 0.83 ALOX5 (0.39) ALOX5NOD2NOD1ALDH1A1NPSR1
SCHEMBL10003677 0.83 SLC2A1 (0.36) ALOX5ALDH1A1NPSR1HTTLMNA
SCHEMBL10003675 0.83 SLC2A1 (0.36) ALOX5ALDH1A1NPSR1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2471786-B1 AMINOPYRAZOLE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2015-11-04 — — EP disclosed
US-8829199-B2 Aminopyrazole derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2014-09-09 — — US disclosed
US-20120208811-A1 Aminopyrazole Derivative F. HOFFMANN-LA ROCHE AG (CH) 2012-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208811-A1 Aminopyrazole Derivative FGFR1, FGFR3, FGFR4 ALOX5 2600/4885NOD2 2641/4885NOD1 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback